A laboratory for early studies of pharmaceuticals intended to treat cancer will be opened in the city of Obninsk, Kaluga region. It will allow to accelerate the market launch of the modern drugs manufactured in Russia, said Sergey Kraevoy, the Deputy Minister of Health of the Russian Federation.
“With the assistance of the Russian Ministry of Industry and Trade, we will soon open here a unique laboratory for early studies of pharmaceuticals,” he said.
Russia’s first medical nuclear cluster, a part of which will be the lab, is currently being established in A.F. Tsyb Medical Radiological Research Center. The facility will test advanced methods for cancer treatment. In particular, Russian-made proton therapy device undergoes clinical testing now. In addition, the investors plan to establish an advanced production facility to manufacture the radiopharmaceuticals.
“We set an ambitious goal for Russia to become an exporter of up-to-date radiopharmaceuticals, including both the diagnostic and therapeutic ones,” said Mr. Kraevoy.
The technetium isotope is used in about 80% of diagnostic procedures in medicine. At the end of 2017, the Institute registered a new advanced double-pin technetium generator and commissioned a modern line for charging the technetium generators. It is expected to produce up to 10 thousands generators a year. The investments in the project amount to about 100 million rubles.